10.3205/16doc123

Ist die AREDS-Supplementierung bei intermediärer AMD kosteneffektiv? Gesundheitsökonomische Evaluation aus Sicht der Leistungserstatter (K)

Full text

German Medical ScienceProvided a free PDF (195.62 KB)

GM16doc123oai:oai-gms.dimdi.de:GM16doc123
Last time updated on July 9, 2019

This paper was published in German Medical Science.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.